![IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-23-06994/article_deploy/html/images/ijms-23-06994-g004.png)
IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML
![Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation - Meng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, Lan-Ping Xu, Xiao-Hui Zhang ... Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation - Meng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, Lan-Ping Xu, Xiao-Hui Zhang ...](https://journals.sagepub.com/cms/10.1177/20406207211072838/asset/images/large/10.1177_20406207211072838-fig4.jpeg)
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation - Meng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, Lan-Ping Xu, Xiao-Hui Zhang ...
![Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2016.229/MediaObjects/41375_2017_Article_BFleu2016229_Fig1_HTML.jpg)
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia | Haematologica
![Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/62be1a5b-cf36-49da-a2af-0a1c33a96a80/gr4_lrg.jpg)
Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation
![Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation | Stem Cell Research & Therapy | Full Text Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13287-022-03170-x/MediaObjects/13287_2022_3170_Fig2_HTML.png)
Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation | Stem Cell Research & Therapy | Full Text
![Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/3c519893-23a9-4078-946a-1fd1e40feff8/gr3.jpg)
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société F
![IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-23-06994/article_deploy/html/images/ijms-23-06994-g001.png)
IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML
![The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis - eClinicalMedicine The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/attachment/682ac112-4688-4fef-8fe2-173a8219b81a/gr1.jpg)
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis - eClinicalMedicine
![Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis - Sidana - 2019 - American Journal of Hematology - Wiley Online Library Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis - Sidana - 2019 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eeac55fc-029c-4cd9-acea-433d4ea6ce68/ajh25566-fig-0001-m.jpg)
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis - Sidana - 2019 - American Journal of Hematology - Wiley Online Library
![CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17 - ScienceDirect CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379120301695-fx1.jpg)
CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17 - ScienceDirect
![Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era - Clinical Lymphoma, Myeloma and Leukemia Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2037463060/2051918605/fx1.jpg)
Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era - Clinical Lymphoma, Myeloma and Leukemia
![Factors responsible for long-term survival in metastatic breast cancer | World Journal of Surgical Oncology | Full Text Factors responsible for long-term survival in metastatic breast cancer | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1477-7819-12-344/MediaObjects/12957_2014_Article_1805_Fig3_HTML.jpg)
Factors responsible for long-term survival in metastatic breast cancer | World Journal of Surgical Oncology | Full Text
![CHARACTERISTICS AND OUTCOMES OF HIV-RELATED BURKITT LYMPHOMA.... EHA Library. Alderuccio J. Jun 12 2020; 295059 CHARACTERISTICS AND OUTCOMES OF HIV-RELATED BURKITT LYMPHOMA.... EHA Library. Alderuccio J. Jun 12 2020; 295059](https://library.ehaweb.org/image/abstracts/eha_2020/EHA-1811/ImagePictures_7675517.png)
CHARACTERISTICS AND OUTCOMES OF HIV-RELATED BURKITT LYMPHOMA.... EHA Library. Alderuccio J. Jun 12 2020; 295059
![Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/10/4/e003472/F3.large.jpg)
Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer
![Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-022-04817-8/MediaObjects/277_2022_4817_Fig4_HTML.png)
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink
![Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0da04648-7c6b-4528-8617-4b055f27c369/gr1.jpg)
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation
![Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2341287922000771:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/qVHBXBqbSQ7FNUvNof+6+l4v03CmyaR9Rm+q8TRfDERovN5wMUmDVyYvA+rI0XvMBqAhgbAUgPlLneQzJhNXQfB28hIz1d+g3e9TdeZbcpcgzN9ZQFyrecMywN4v0hqWnSw1vXLOvJoTkEvNx/ckpHkPBKuGIqSzrdNd2XTBqASNnXO8OIFMftXYHbFKXRK6osyXGJFZGECmEuQwJtg85l901lOp0hPwiRcRrEmhXfx0aORXzTPfzv/hjZ5/CFlP494w6TqOc5+mMuoewRQII=)
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría
![Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission | Bone Marrow Transplantation Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-020-0936-z/MediaObjects/41409_2020_936_Fig1_HTML.png)
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission | Bone Marrow Transplantation
![Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study](https://www.frontiersin.org/files/Articles/858202/fonc-12-858202-HTML/image_m/fonc-12-858202-g001.jpg)
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
![Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation ... Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2053935579/2060401307/jcyt636-fig-0003.jpg)